[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit ::
Main Menu
Home::
Journal Information::
Articles Archive::
Guide for Authors::
For Reviewers::
Ethical Statements::
Registration::
Site Facilities::
Contact us::
::
Indexed by
    
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
Copyright Policies

 

AWT IMAGE

 

..
Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

..
:: Volume 3 - The Autumn Supplement of Shefaye Khatam 3 - ::
Shefaye Khatam 2015, 3 - The Autumn Supplement of Shefaye Khatam 3 -: 47-47 Back to browse issues page
P20: Progesterone in TBI Treatment
Elham Mohammadzadeh *
a. Shefa Neuroscience Research, Khatam Alanbia Hospital, Tehran, Iran b. Department of Biology and Anatomical Sciences, Faculty of Medicine, Shahid Beheshti University of Medical Sciences,Tehran, Iran , elhammohammadzadeh85@gmail.com
Abstract:   (4223 Views)

The brain edema is one of remarkable injuries after traumatic brain injuries (TBI). The common treatments for limiting edema are included mannitol, barbiturates, corticosteroids, hyperventilation and central nervous system derange. The most of these treatments for edema is problematic. For example, mannitol can be effective for the short period of time (24 hours) after brain injuries but is not appropriate for long-term treatments after TBI. Also, the application of corticosteroids such as methylprednisolone was encountered with limited treatments. On the other hand, the studies were shown that biological gender effects incidence and the result of ischemia and TBI and gender and menstruation may have an effect on animal response to experimental TBI and finally lead to progesterone development as a neuroprotective factors. Progesterone is synthesized in males and females’ brain by oligodendrocytes and some neurons in equally volume. Progesterone receptors are expressed in adult brain, thus the various regions of brain are natural target of progesterone. The investigations on progesterone were shown that this hormone has been used as a treatment after injury due to stroke and TBI in males and females. Moreover, animal studies were shown that the use of progesterone after experimental TBI decreases neuronal apoptosis and limit gliosis. progesterone injection leads to decrease neuronal death, increase remyelination and improve function and overall decrease in brain edema.

Keywords: Progesterone, TBI, Edema
Full-Text [PDF 167 kb]   (1279 Downloads)    
Type of Study: Review --- Open Access, CC-BY-NC | Subject: Basic research in Neuroscience


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mohammadzadeh E. P20: Progesterone in TBI Treatment . Shefaye Khatam 2015; 3 (S3) :47-47
URL: http://shefayekhatam.ir/article-1-864-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 3 - The Autumn Supplement of Shefaye Khatam 3 - Back to browse issues page
مجله علوم اعصاب شفای خاتم The Neuroscience Journal of Shefaye Khatam
Persian site map - English site map - Created in 0.05 seconds with 47 queries by YEKTAWEB 4660